The Global High Content Screening Market is estimated at USD 485.19 million in 2017 and is poised to reach USD 777.87 million by the end of 2022, growing at a CAGR of 9.9% during the forecast period.
High-content analysis (HCA) or high-content screening (HCS) defines a set of programmed diagnostic methods using integrated microscopy, image processing, and visualization gears to mine data from cells or cell populations and report quantitative results. Over the past five years, a majority of HTS laboratories have adopted high-content screening (HCS) in their operations. As HTS laboratories have sought more biologically-relevant assays, cell-based assays, and high content screening technologies have become more widespread. More than three-quarters of the academic laboratories have implemented HCS technologies, while to some extent over half of the pharma/biotech HTS laboratories use HCS technologies in their high throughput screening operations. While a bulk of academic institutes and pharma/biotech firms have implemented some HCS technologies, a small section of contract research organizations uses HCS technologies. Approximately, one-quarter of the contract research organizations use HCS technologies in their laboratories.
Get a PDF Sample of Global High Content Screening (HTS) Market Research Report @ http://www.orbisresearch.com/contacts/request-sample/220491
Market Dynamics Drivers
Rapid technological advances, increased government spending & private investments, increased adoption of high-content screening and product innovations are the major drivers of the high content screening market.
Expensive equipment and lack of properly skilled labor are the major restraints faced by the market.
The global high content screening market can be segmented by –
Geographically, the global high content screening is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and Latin America. Currently, North America is the largest market for high content screening, which can be attributed to the increasing incidence of chronic diseases, various collaborations with research institutes and partnerships among the major players for developing and marketing new products.
Becton Dickinson and Company
Yokogawa Electric Corporation
Thermo Fisher Scientific
Cell Signaling Technologies
Place a Purchase Order For this Report @:http://www.orbisresearch.com/contact/purchase/220491
Market analysis for the global high content screening market, with region specific assessments and competition analysis.
Market definition along with the identification of key drivers, restraints opportunities and challenges.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with company profiles of key players with the analysis of their current strategic interests and key financial information.
Identification and analysis of the macro and micro factors that affect the global high content screening market.
Insights of the market in the regions that have the highest potential for growth and also identify the markets that are still untapped.